Cargando…

Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments

A diagnosis of Parkinson's disease is classically established after the manifestation of motor symptoms such as rigidity, bradykinesia, and tremor. However, a growing body of evidence supports the hypothesis that nonmotor symptoms, especially gastrointestinal dysfunctions, could be considered a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poirier, Andrée-Anne, Aubé, Benoit, Côté, Mélissa, Morin, Nicolas, Di Paolo, Thérèse, Soulet, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168460/ https://www.ncbi.nlm.nih.gov/pubmed/28050310 http://dx.doi.org/10.1155/2016/6762528

Ejemplares similares

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models
por: Bourque, Mélanie, et al.
Publicado: (2021)

Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
por: Isenbrandt, Amandine, et al.
Publicado: (2023)

Gastrointestinal Dysfunction in Parkinson’s Disease
por: Skjærbæk, Casper, et al.
Publicado: (2021)

Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease
por: Kim, Joong-Seok, et al.
Publicado: (2015)

Gastrointestinal Dysfunction in Chinese Patients with Parkinson's Disease
por: Qin, Xiaoling, et al.
Publicado: (2019)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease
por: Bhattarai, Yogesh, et al.
Publicado: (2021)

Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
por: Han, Myat Noe, et al.
Publicado: (2022)

Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
por: Morin, Nicolas, et al.
Publicado: (2014)

Multiphoton intravital microscopy in small animals: motion artefact challenges and technical solutions
por: SOULET, D., et al.
Publicado: (2020)

Prevalence of Malnutrition in Parkinson's Disease and Correlation with Gastrointestinal Symptoms
por: Paul, Birinder Singh, et al.
Publicado: (2019)

Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson's Disease
por: Shu, Li, et al.
Publicado: (2018)

Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson's Disease
por: Xiao-ling, Qin, et al.
Publicado: (2021)

Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review
por: Salari, Mehri, et al.
Publicado: (2016)

The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease
por: Sung, Hye-Young, et al.
Publicado: (2014)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson's Disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2020)

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

Effect of Docosahexaenoic Acid (DHA) at the Enteric Level in a Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2021)

Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
por: Lamontagne-Proulx, Jérôme, et al.
Publicado: (2023)

Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
por: Perez-Pardo, Paula, et al.
Publicado: (2017)

Retraction: Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review
Publicado: (2017)

Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem
por: Tan, Ai Huey, et al.
Publicado: (2023)

Effect of Olfactory and Gustatory Dysfunction and Motor Symptoms on Body Weight in Patients with Parkinson’s Disease
por: Masala, Carla, et al.
Publicado: (2020)

A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s disease
por: Jones, Jacob D., et al.
Publicado: (2021)

Impact of outpatient gastroenterology consult on pharmacotherapy and management of gastrointestinal symptoms in Parkinson’s Disease
por: Chang, Jocelyn J., et al.
Publicado: (2023)

Balance Dysfunction in Parkinson's Disease
por: Rinalduzzi, Steno, et al.
Publicado: (2015)

Unawareness of Apathy in Parkinson’s Disease: The Role of Executive Dysfunction on Symptom Recognition
por: Maggi, Gianpaolo, et al.
Publicado: (2023)

A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson’s disease
por: Song, Bin, et al.
Publicado: (2022)

Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson's Disease Cohort
por: Kenna, Jade E., et al.
Publicado: (2022)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson’s Disease and in Neurologically Intact Subjects
por: Lee, Hyo Jeong, et al.
Publicado: (2018)

Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
por: Batla, Amit, et al.
Publicado: (2016)

Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease
por: McNamara, Patrick, et al.
Publicado: (2006)

Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system
por: Soulet, Denis, et al.
Publicado: (2003)

Treatment of psychotic symptoms in patients with Parkinson disease
por: Chen, Jack J.
Publicado: (2018)

mGlu5, Dopamine D(2) and Adenosine A(2A) Receptors in L-DOPA-induced Dyskinesias
por: Morin, Nicolas, et al.
Publicado: (2016)

Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction
por: Franciotti, Raffaella, et al.
Publicado: (2019)

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
por: Hauser, Robert A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aps3atnvkd1tlrip75itkst8c8